SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-18-001289
Filing Date
2018-04-12
Accepted
2018-04-12 17:29:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d07422027_04122018.htm SC 13D 232082
2 JOINT FILING AGREEMENT ex991to13d07422027_04122018.htm EX-99.1 17159
  Complete submission text file 0000921895-18-001289.txt   250995
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-60943 | Film No.: 18752785
SIC: 2834 Pharmaceutical Preparations